Cargando…

13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico

The biological activities of dehydrocostus lactone and its analogues are suggested to be mediated by the lactone ring and α,β-methylene-γ-lactone. However, few studies exist on the structure-activity relationship of 13-amino derivatives of dehydrocostus latone. In this study new 13-amino derivatives...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemboi, Douglas, Langat, Moses K., Siwe-Noundou, Xavier, Tshiwawa, Tendamudzimu, Krause, Rui W. M., Davison, Candace, Smit, Christie Jane, de la Mare, Jo-Anne, Tembu, Vuyelwa Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397875/
https://www.ncbi.nlm.nih.gov/pubmed/35998145
http://dx.doi.org/10.1371/journal.pone.0271389
_version_ 1784772217228230656
author Kemboi, Douglas
Langat, Moses K.
Siwe-Noundou, Xavier
Tshiwawa, Tendamudzimu
Krause, Rui W. M.
Davison, Candace
Smit, Christie Jane
de la Mare, Jo-Anne
Tembu, Vuyelwa Jacqueline
author_facet Kemboi, Douglas
Langat, Moses K.
Siwe-Noundou, Xavier
Tshiwawa, Tendamudzimu
Krause, Rui W. M.
Davison, Candace
Smit, Christie Jane
de la Mare, Jo-Anne
Tembu, Vuyelwa Jacqueline
author_sort Kemboi, Douglas
collection PubMed
description The biological activities of dehydrocostus lactone and its analogues are suggested to be mediated by the lactone ring and α,β-methylene-γ-lactone. However, few studies exist on the structure-activity relationship of 13-amino derivatives of dehydrocostus latone. In this study new 13-amino derivatives of dehydrocostus lactone DHLC (1–4) were synthesized through Michael addition reactions, and were screened against three different breast cancer cell lines, namely hormone receptor positive breast cancer (MCF-7), triple-negative breast cancer (HCC70), and non-tumorigenic mammary epithelial (MCF-12A) cell lines. Dehydrocostus lactone (DHLC) exhibited IC(50) values of 1.11 (selectivity index (SI) = 0.06), 24.70 (SI = 0.01) and 0.07 μM against HCC70, MCF-7 and MCF-12A cells, respectively. All the amino derivatives, except DHLC-3 displayed low micromolar IC(50) values (ranging from 0.07–4.24 μM) against both breast cancer cell lines, with reduced toxicity towards MCF-12A non-tumorigenic mammary epithelial cells (SI values ranging from 6.00–126.86). DHLC-1 and DHLC-2 demonstrated the greatest selectivity for the MCF-7 cells (with SI of 121 and 126.86 respectively) over the MCF-12A cells. This reveals that, overall, the derivatives display greatly improved selectivity for breast cancer over non-tumorigenic mammary epithelial cells, with between 100-fold and 12 000-fold higher SI values. The improved docking scores were recorded for all the 13-amino dehydrocostus lactone derivatives for the enzymes analyzed. Compounds DHLC-4, and DHLC-3 recorded higher docking scores of -7.33 and -5.97 Kca/mol respectively, compared to the parent structure, dehydrocostus lactone (-5.34 Kca/mol) for protein kinase (PKC) theta (1XJD) and -6.22 and -5.88 Kca/mol, respectively for protein kinase iota (1RZR). The compounds further showed promising predicted adsorption, distribution, metabolisms and excretion (ADME) properties. Predicting the ADME properties of these derivatives is of importance in evaluating their drug-likeness, which could in turn be developed into potential drug candidates.
format Online
Article
Text
id pubmed-9397875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93978752022-08-24 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico Kemboi, Douglas Langat, Moses K. Siwe-Noundou, Xavier Tshiwawa, Tendamudzimu Krause, Rui W. M. Davison, Candace Smit, Christie Jane de la Mare, Jo-Anne Tembu, Vuyelwa Jacqueline PLoS One Research Article The biological activities of dehydrocostus lactone and its analogues are suggested to be mediated by the lactone ring and α,β-methylene-γ-lactone. However, few studies exist on the structure-activity relationship of 13-amino derivatives of dehydrocostus latone. In this study new 13-amino derivatives of dehydrocostus lactone DHLC (1–4) were synthesized through Michael addition reactions, and were screened against three different breast cancer cell lines, namely hormone receptor positive breast cancer (MCF-7), triple-negative breast cancer (HCC70), and non-tumorigenic mammary epithelial (MCF-12A) cell lines. Dehydrocostus lactone (DHLC) exhibited IC(50) values of 1.11 (selectivity index (SI) = 0.06), 24.70 (SI = 0.01) and 0.07 μM against HCC70, MCF-7 and MCF-12A cells, respectively. All the amino derivatives, except DHLC-3 displayed low micromolar IC(50) values (ranging from 0.07–4.24 μM) against both breast cancer cell lines, with reduced toxicity towards MCF-12A non-tumorigenic mammary epithelial cells (SI values ranging from 6.00–126.86). DHLC-1 and DHLC-2 demonstrated the greatest selectivity for the MCF-7 cells (with SI of 121 and 126.86 respectively) over the MCF-12A cells. This reveals that, overall, the derivatives display greatly improved selectivity for breast cancer over non-tumorigenic mammary epithelial cells, with between 100-fold and 12 000-fold higher SI values. The improved docking scores were recorded for all the 13-amino dehydrocostus lactone derivatives for the enzymes analyzed. Compounds DHLC-4, and DHLC-3 recorded higher docking scores of -7.33 and -5.97 Kca/mol respectively, compared to the parent structure, dehydrocostus lactone (-5.34 Kca/mol) for protein kinase (PKC) theta (1XJD) and -6.22 and -5.88 Kca/mol, respectively for protein kinase iota (1RZR). The compounds further showed promising predicted adsorption, distribution, metabolisms and excretion (ADME) properties. Predicting the ADME properties of these derivatives is of importance in evaluating their drug-likeness, which could in turn be developed into potential drug candidates. Public Library of Science 2022-08-23 /pmc/articles/PMC9397875/ /pubmed/35998145 http://dx.doi.org/10.1371/journal.pone.0271389 Text en © 2022 Kemboi et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kemboi, Douglas
Langat, Moses K.
Siwe-Noundou, Xavier
Tshiwawa, Tendamudzimu
Krause, Rui W. M.
Davison, Candace
Smit, Christie Jane
de la Mare, Jo-Anne
Tembu, Vuyelwa Jacqueline
13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title_full 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title_fullStr 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title_full_unstemmed 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title_short 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
title_sort 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397875/
https://www.ncbi.nlm.nih.gov/pubmed/35998145
http://dx.doi.org/10.1371/journal.pone.0271389
work_keys_str_mv AT kemboidouglas 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT langatmosesk 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT siwenoundouxavier 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT tshiwawatendamudzimu 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT krauseruiwm 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT davisoncandace 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT smitchristiejane 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT delamarejoanne 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico
AT tembuvuyelwajacqueline 13aminoderivativesofdehydrocostuslactonedisplaygreatlyenhancedselectivetoxicityagainstbreastcancercellsandimprovedbindingenergiestoproteinkinasesinsilico